Cargando…

Low molecular weight heparin versus other anti-thrombotic agents for prevention of venous thromboembolic events after total hip or total knee replacement surgery: a systematic review and meta-analysis

BACKGROUND: Venous thromboembolism (VTE) is an important complication following total hip replacement (THR) and total knee replacement (TKR) surgeries. Aim of this study was to comprehensively compare the clinical outcomes of low-molecular-weight heparin (LMWH) with other anticoagulants in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Xin, Lin, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6129001/ https://www.ncbi.nlm.nih.gov/pubmed/30193575 http://dx.doi.org/10.1186/s12891-018-2215-3

Ejemplares similares

Venous Thromboembolism in Total Hip and Total Knee Arthroplasty
por: Simon, Samantha J., et al.
Publicado: (2023)

Spontaneous Heparin-Induced Thrombocytopenia and Venous Thromboembolism following Total Knee Arthroplasty
por: Baker, Kevin, et al.
Publicado: (2017)

The Efficacy and Safety of Rivaroxaban for Venous Thromboembolism Prophylaxis after Total Hip and Total Knee Arthroplasty
por: Russell, Robert D., et al.
Publicado: (2013)

Venous thromboembolism after total knee and hip arthroplasty: A retrospective study
por: Almegren, Mosaad O., et al.
Publicado: (2018)

Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement
por: Dranitsaris, George, et al.
Publicado: (2011)

Changes of thrombelastography in patients undergoing elective primary total knee and total hip replacement with low molecular heparin prophylaxis
por: Yang, Yi, et al.
Publicado: (2014)

What are the incidence and risk factors of in-hospital mortality after venous thromboembolism events in total hip and knee arthroplasty patients?
por: Shahi, Alisina, et al.
Publicado: (2018)

Cost-Utility Analysis of Venous Thromboembolism Prophylaxis Strategies for People Undergoing Elective Total Hip and Total Knee Replacement Surgeries in the English National Health Service
por: Dawoud, Dalia M., et al.
Publicado: (2018)

Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China
por: Yan, Xiaoyu, et al.
Publicado: (2016)

The role of aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis after total knee arthroplasty: a meta-analysis of randomized controlled trials
por: Meng, Jiahao, et al.
Publicado: (2023)

Effect of Comorbidity Burden on the Risk of Venous Thromboembolic Events After Total Knee Arthroplasty
por: Bala, Abiram, et al.
Publicado: (2021)

Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
por: Levitan, Bennett, et al.
Publicado: (2014)

Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery
por: Wurnig, Christian, et al.
Publicado: (2015)

Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidences in ten years
por: Zhang, Zi-hao, et al.
Publicado: (2015)

Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism after total hip replacement: A meta-analysis
por: Dong, Wen-Jun, et al.
Publicado: (2016)

Low-molecular-weight heparins in the treatment of venous thromboembolism
por: Ageno , Walter, et al.
Publicado: (2000)

Testosterone Therapy, Thrombophilia, Venous Thromboembolism, and Thrombotic Events
por: Glueck, Charles J., et al.
Publicado: (2018)

Total Hip and Knee Replacement in the Mature Athlete
por: Bloomfield, Michael R., et al.
Publicado: (2014)

Urinary Prothrombin Fragment 1+2 in relation to Development of Non-Symptomatic and Symptomatic Venous Thromboembolic Events following Total Knee Replacement
por: Borris, Lars C., et al.
Publicado: (2011)

Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty
por: Akamine, Akihiko, et al.
Publicado: (2022)

Anticipating Urinary Retention Following Total Hip and Total Knee Replacements
por: Hamed, Y, et al.
Publicado: (2020)

Why differentiate low molecular weight heparins for venous thromboembolism?
por: Fareed, Jawed, et al.
Publicado: (2007)

Risk of venous thromboembolism after total hip and knee replacement in older adults with comorbidity and co-occurring comorbidities in the Nationwide Inpatient Sample (2003-2006)
por: Kapoor, Alok, et al.
Publicado: (2010)

Readability of Information on Smartphone Apps for Total Hip Replacement and Total Knee Replacement Surgery Patients
por: Bahadori, Shayan, et al.
Publicado: (2019)

Current status survey of the extramural hospital management of venous thromboembolism after total hip and knee arthroplasty in China
por: Tong, Kai, et al.
Publicado: (2021)

Nursing Care and Barriers for Prevention of Venous Thromboembolism in Total Knee and Hip Arthroplasty Patients: A Qualitative Study
por: Al-Mugheed, Khalid, et al.
Publicado: (2023)

Association of the Comprehensive Care for Joint Replacement Model With Disparities in the Use of Total Hip and Total Knee Replacement
por: Thirukumaran, Caroline P., et al.
Publicado: (2021)

Intermittent Pneumatic Compression for the Prevention of Venous Thromboembolism after Total Hip Arthroplasty
por: Kwak, Hong Suk, et al.
Publicado: (2017)

Serum D-dimer should not be used in the diagnosis of venous thromboembolism within 28 days of total knee replacement surgery
por: Toner, Ethan, et al.
Publicado: (2020)

Heparin ‘flush’ induced thrombocytopenia triggered by total hip replacement: a case report
por: Yoshida, Ruka, et al.
Publicado: (2020)

The Efficacy of Low Molecular Weight Heparin for the Prevention of Venous Thromboembolism after Hip Fracture Surgery in Korean Patients
por: Kim, Kwang-Kyoun, et al.
Publicado: (2016)

Venous thromboembolism is rare after total hip and knee joint arthroplasty with long thromboprophylaxis in Finnish fast-track hospitals
por: Moisander, Annette M., et al.
Publicado: (2023)

Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer
por: Lee, Jang Ho, et al.
Publicado: (2019)

Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin versus warfarin
por: Goel, R., et al.
Publicado: (2018)

Fatal pulmonary thromboembolism during total hip replacement under spinal anesthesia
por: Cho, Yong-Hyun, et al.
Publicado: (2013)

Prophylaxis for Venous Thromboembolism Following Total Knee Arthroplasty: A Survey of Korean Knee Surgeons
por: Kim, Nam Ki, et al.
Publicado: (2016)

Risk‐Stratified Venous Thromboembolism Prophylaxis after Total Joint Arthroplasty: Low Molecular Weight Heparins and Sequential Aspirin vs Aggressive Chemoprophylaxis
por: Peng, Hui‐ming, et al.
Publicado: (2021)

Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study
por: Zhou, Li-Bo, et al.
Publicado: (2023)

Knee Load Distribution in Hip Osteoarthritis Patients After Total Hip Replacement
por: van Drongelen, Stefan, et al.
Publicado: (2020)

Comparison of Apixaban and Low Molecular Weight Heparin in Preventing Deep Venous Thrombosis after Total Knee Arthroplasty in Older Adults
por: Jiang, Hui, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5mh9sjfe9i24j054bs2gkgqqok